mibefradil has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumont, L; Jasmin, G; Paquette, F | 1 |
| Poole-Wilson, PA; van Veldhuisen, DJ | 1 |
| Beltrame, JF; Ganz, P | 1 |
1 review(s) available for mibefradil and cardiovascular agents
| Article | Year |
|---|---|
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
Topics: Bosentan; Cardiovascular Agents; Deoxyepinephrine; Heart Failure; Humans; Imidazoles; Mibefradil; Pyrazines; Quinolines; Sulfonamides; Xamoterol | 2001 |
2 other study(ies) available for mibefradil and cardiovascular agents
| Article | Year |
|---|---|
Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters.
Topics: Animals; Biomarkers; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Cardiovascular Agents; Cricetinae; Female; Heart; Male; Mibefradil; Muscle, Skeletal; Myocardium; Necrosis; Time Factors; Tongue; Verapamil | 1999 |
Evaluating patients with persistent chest pain and no obstructive coronary artery disease.
Topics: Angina Pectoris; Animals; Blood Flow Velocity; Cardiovascular Agents; Chest Pain; Coronary Circulation; Coronary Disease; Diagnosis, Differential; Humans; Mibefradil; Quality of Life; Randomized Controlled Trials as Topic; Rest; Vasodilator Agents | 2009 |